吉妥珠单抗奥唑米星治疗伴有MLL/AF9的难治性急性髓系白血病达到完全分子缓解 - Suppr

Suppr

超能文献

Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin.

作者信息

Asano Hiroki, Yamamoto Go, Hosoi Masataka, Takahashi Tsuyoshi, Hangaishi Akira, Kurokawa Mineo

出版信息

Leuk Res. 2010 Jul;34(7):e152-3. doi: 10.1016/j.leukres.2009.12.006. Epub 2010 Jan 12.

DOI:10.1016/j.leukres.2009.12.006

PMID:20061019

Abstract

摘要

相似文献

Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin.

Leuk Res. 2010 Jul;34(7):e152-3. doi: 10.1016/j.leukres.2009.12.006. Epub 2010 Jan 12.

Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.

Haematologica. 2003 Dec;88(12):ECR37.

Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.

Leukemia. 2008 Jun;22(6):1273-4. doi: 10.1038/sj.leu.2405029. Epub 2007 Nov 8.

The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.

Haematologica. 2005 Dec;90(12):1626-34.

Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.

Leuk Res. 2008 Dec;32(12):1800-8. doi: 10.1016/j.leukres.2008.05.011. Epub 2008 Jul 14.

Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene.

Ann Hematol. 2012 Sep;91(9):1491-3. doi: 10.1007/s00277-012-1417-2. Epub 2012 Feb 4.

Gemtuzumab ozogamicin: time to resurrect?

J Clin Oncol. 2012 Nov 10;30(32):3921-3. doi: 10.1200/JCO.2012.43.0132. Epub 2012 Sep 17.

Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance.

Leukemia. 2002 Sep;16(9):1870-1. doi: 10.1038/sj.leu.2402594.

Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.

Haematologica. 2004 Jun 1;89(6 Suppl):ECR18.

[Standard therapies for acute myeloid leukemia].

Rinsho Ketsueki. 2009 Oct;50(10):1389-400.

引用本文的文献

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.

Cancers (Basel). 2021 Sep 11;13(18):4566. doi: 10.3390/cancers13184566.

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin.

Cancers (Basel). 2021 Jun 28;13(13):3214. doi: 10.3390/cancers13133214.

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.

Int J Mol Sci. 2020 Aug 6;21(16):5626. doi: 10.3390/ijms21165626.

Antibody-dependent cell-mediated cytotoxicity overcomes NK cell resistance in MLL-rearranged leukemia expressing inhibitory KIR ligands but not activating ligands.

Clin Cancer Res. 2012 Nov 15;18(22):6296-305. doi: 10.1158/1078-0432.CCR-12-0668. Epub 2012 Sep 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验